Matches in SemOpenAlex for { <https://semopenalex.org/work/W2003227963> ?p ?o ?g. }
- W2003227963 endingPage "62" @default.
- W2003227963 startingPage "55" @default.
- W2003227963 abstract "Tamm-Horsfall protein (THP) powerfully inhibits calcium oxalate crystal aggregation, but structurally abnormal THPs from recurrent calcium stone formers may promote crystal aggregation. Therefore, increased urinary excretion of abnormal THP might be of relevance in nephrolithiasis. We studied 44 recurrent idiopathic calcium stone formers with a positive family history of stone disease (RCSFfam) and 34 age- and sex-matched healthy controls (C). Twenty-four-hour urinary THP excretion was measured by enzyme linked immunosorbent assay. Structural properties of individually purified THPs were obtained from analysis of elution patterns from a Sepharose 4B column. Sialic acid (SA) contents of native whole 24-h urines, crude salt precipitates of native urines and individually purified THPs were measured. THP function was studied by measuring inhibition of CaOx crystal aggregation in vitro (pH 5.7, 200 mM sodium chloride). Twenty-four-hour urine excretion of THP was higher in RCSFfam (44.0 ± 4.0 mg/day) than in C (30.9 ± 2.2 mg/day, P = 0.015). Upon salt precipitation and lyophilization, elution from a Sepharose 4B column revealed one major peak (peak A, cross-reacting with polyclonal anti-THP antibody) and a second minor peak (peak B, not cross-reacting). THPs from RCSFfam eluted later than those from C (P = 0.021), and maximum width of THP peaks was higher in RCSFfam than in C (P = 0.024). SA content was higher in specimens from RCSFfam than from C, in native 24-h urines (207.5 ± 20.4 mg vs. 135.2 ± 16.1 mg, P = 0.013) as well as in crude salt precipitates of 24-h urines (10.4 ± 0.5 mg vs. 7.4 ± 0.9 mg, P = 0.002) and in purified THPs (75.3 ± 9.3 μg/mg vs. 48.8 ± 9.8 μg/mg THP, P = 0.043). Finally, inhibition of calcium oxalate monohydrate crystal aggregation by 40 mg/L of THP was lower in RCSFfam (6.1 ± 5.5%, range −62.0 to +84.2%) than in C (24.9 ± 6.0%, range −39.8 to +82.7%), P = 0.022, and only 25 out of 44 (57%) THPs from RCSFfam were inhibitory (positive inhibition value) vs. 25 out of 34 (74%) THPs from C, P < 0.05. In conclusion, severely recurrent calcium stone formers with a positive family history excrete more THP than healthy controls, and their THP molecules elute later from an analytical column and contain more SA. Such increasingly aggregated THP molecules predispose to exaggerated calcium oxalate crystal aggregation, an important prerequisite for urinary stone formation." @default.
- W2003227963 created "2016-06-24" @default.
- W2003227963 creator A5009135873 @default.
- W2003227963 creator A5021121335 @default.
- W2003227963 creator A5026144596 @default.
- W2003227963 creator A5057368807 @default.
- W2003227963 date "2007-03-08" @default.
- W2003227963 modified "2023-10-07" @default.
- W2003227963 title "Tamm-Horsfall protein in recurrent calcium kidney stone formers with positive family history: abnormalities in urinary excretion, molecular structure and function" @default.
- W2003227963 cites W108682491 @default.
- W2003227963 cites W1768831284 @default.
- W2003227963 cites W1771691146 @default.
- W2003227963 cites W1963630065 @default.
- W2003227963 cites W1987047294 @default.
- W2003227963 cites W1990804549 @default.
- W2003227963 cites W1991042458 @default.
- W2003227963 cites W1995703837 @default.
- W2003227963 cites W2017898622 @default.
- W2003227963 cites W2019260895 @default.
- W2003227963 cites W2020696278 @default.
- W2003227963 cites W2022548242 @default.
- W2003227963 cites W2027877403 @default.
- W2003227963 cites W2065964952 @default.
- W2003227963 cites W2067021754 @default.
- W2003227963 cites W2072349152 @default.
- W2003227963 cites W2094922355 @default.
- W2003227963 cites W2096413599 @default.
- W2003227963 cites W2113290069 @default.
- W2003227963 cites W2121793978 @default.
- W2003227963 cites W2139492744 @default.
- W2003227963 cites W2152393548 @default.
- W2003227963 cites W2156729608 @default.
- W2003227963 cites W2329840375 @default.
- W2003227963 cites W2341916832 @default.
- W2003227963 cites W2356306597 @default.
- W2003227963 cites W2407510426 @default.
- W2003227963 cites W2463750192 @default.
- W2003227963 cites W2465627419 @default.
- W2003227963 cites W4301969111 @default.
- W2003227963 doi "https://doi.org/10.1007/s00240-007-0083-7" @default.
- W2003227963 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17345077" @default.
- W2003227963 hasPublicationYear "2007" @default.
- W2003227963 type Work @default.
- W2003227963 sameAs 2003227963 @default.
- W2003227963 citedByCount "42" @default.
- W2003227963 countsByYear W20032279632012 @default.
- W2003227963 countsByYear W20032279632013 @default.
- W2003227963 countsByYear W20032279632014 @default.
- W2003227963 countsByYear W20032279632015 @default.
- W2003227963 countsByYear W20032279632016 @default.
- W2003227963 countsByYear W20032279632017 @default.
- W2003227963 countsByYear W20032279632018 @default.
- W2003227963 countsByYear W20032279632019 @default.
- W2003227963 countsByYear W20032279632021 @default.
- W2003227963 countsByYear W20032279632022 @default.
- W2003227963 countsByYear W20032279632023 @default.
- W2003227963 crossrefType "journal-article" @default.
- W2003227963 hasAuthorship W2003227963A5009135873 @default.
- W2003227963 hasAuthorship W2003227963A5021121335 @default.
- W2003227963 hasAuthorship W2003227963A5026144596 @default.
- W2003227963 hasAuthorship W2003227963A5057368807 @default.
- W2003227963 hasBestOaLocation W20032279632 @default.
- W2003227963 hasConcept C10146269 @default.
- W2003227963 hasConcept C126322002 @default.
- W2003227963 hasConcept C134018914 @default.
- W2003227963 hasConcept C178790620 @default.
- W2003227963 hasConcept C185592680 @default.
- W2003227963 hasConcept C2776179656 @default.
- W2003227963 hasConcept C2777724520 @default.
- W2003227963 hasConcept C2779728849 @default.
- W2003227963 hasConcept C2780026642 @default.
- W2003227963 hasConcept C43617362 @default.
- W2003227963 hasConcept C519063684 @default.
- W2003227963 hasConcept C537181965 @default.
- W2003227963 hasConcept C55493867 @default.
- W2003227963 hasConcept C71924100 @default.
- W2003227963 hasConcept C73826308 @default.
- W2003227963 hasConcept C74460091 @default.
- W2003227963 hasConcept C77411442 @default.
- W2003227963 hasConceptScore W2003227963C10146269 @default.
- W2003227963 hasConceptScore W2003227963C126322002 @default.
- W2003227963 hasConceptScore W2003227963C134018914 @default.
- W2003227963 hasConceptScore W2003227963C178790620 @default.
- W2003227963 hasConceptScore W2003227963C185592680 @default.
- W2003227963 hasConceptScore W2003227963C2776179656 @default.
- W2003227963 hasConceptScore W2003227963C2777724520 @default.
- W2003227963 hasConceptScore W2003227963C2779728849 @default.
- W2003227963 hasConceptScore W2003227963C2780026642 @default.
- W2003227963 hasConceptScore W2003227963C43617362 @default.
- W2003227963 hasConceptScore W2003227963C519063684 @default.
- W2003227963 hasConceptScore W2003227963C537181965 @default.
- W2003227963 hasConceptScore W2003227963C55493867 @default.
- W2003227963 hasConceptScore W2003227963C71924100 @default.
- W2003227963 hasConceptScore W2003227963C73826308 @default.
- W2003227963 hasConceptScore W2003227963C74460091 @default.
- W2003227963 hasConceptScore W2003227963C77411442 @default.
- W2003227963 hasIssue "2" @default.
- W2003227963 hasLocation W20032279631 @default.